Department of Endocrinology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India.
University of Cambridge Metabolic Research Laboratories, Wellcome Trust-Medical Research Council Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom.
Thyroid. 2022 Feb;32(2):215-218. doi: 10.1089/thy.2021.0478.
The sodium-iodide symporter (NIS, SLC5A5) is expressed at the basolateral membrane of the thyroid follicular cell, and facilitates the thyroidal iodide uptake required for thyroid hormone biosynthesis. Biallelic loss-of-function mutations in NIS are a rare cause of dyshormonogenic congenital hypothyroidism. Affected individuals typically exhibit a normally sited, often goitrous thyroid gland, with absent uptake of radioiodine in the thyroid and other NIS-expressing tissues. We report a novel homozygous NIS mutation (c.1067 C>T, p.S356F) in four siblings from a consanguineous Indian kindred, presenting with significant hypothyroidism. Functional characterization of the mutant protein demonstrated impaired plasma membrane localization and cellular iodide transport.
钠碘同向转运体(NIS,SLC5A5)表达于甲状腺滤泡细胞的基底外侧膜,促进甲状腺激素生物合成所需的甲状腺碘摄取。NIS 的双等位基因失活突变是先天性甲状腺功能减退症的罕见病因。受影响的个体通常表现为甲状腺位置正常,常伴有甲状腺肿,甲状腺和其他 NIS 表达组织中放射性碘摄取缺失。我们报道了来自一个近亲印度血统的四个兄弟姐妹中一种新的纯合 NIS 突变(c.1067 C>T,p.S356F),他们表现出明显的甲状腺功能减退症。对突变蛋白的功能特征分析表明,其质膜定位和细胞碘转运受损。